Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bernie sanders
biotech
boston
boston blog main
boston top stories
cancer
cancer immunotherapy
center for medicare and medicaid services
companion diagnostic
daniel o'day
deals
dow jones
fda
foundation medicine
foundationone cdx
foundationone heme
genentech
headlines
life sciences
medicare for all
national blog main
national top stories
new york blog main
news
osimertinib
politics
roche
rucaparib (rubraca)
san francisco blog main
u.s. market news
unitedhealth group
What
momentum
2
×
stock
2
×
struggled
acquire
agreed
bernie
big
billion
blame
broad
broader
ccn
confidence
culprits
declines
didn’t
dow
flirted
foundation
gain
genentech
health
key
market
medicare
medicine
morning
panels
pay
pays
picked
plunging
positive
profiling
recently
redux
remaining
rest
roche
sanders
Language
Current search:
stock
×
momentum
×
@ccn.com
5 years ago
Key Dow Stocks Are Plunging – Blame Bernie Sanders
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
